TITLE:
A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

CONDITION:
Stroke

INTERVENTION:
traxiprodil (CP-101,606)

SUMMARY:

      The purpose of this study is to determine whether a new research medication is effective and
      safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 40 Years to 90 Years
Criteria:

        Inclusion Criteria:

        Males & females age 40-90 years

        Enrolled in study within 6 hours of onset of stroke symptoms

        Willing to sign informed consent form

        No significant disabilities prior to stroke

        Exclusion Criteria:

        Treatment with t-PA (tissue plasminogen activator)

        Premorbid modified rankin scale score of 2 or more
      
